News

Cathy Tie slips on a white lab coat bearing her name and the logo of her startup: Origin Genomics. "Welcome!" she says as she leads an NPR reporter, photographer and videographer on an exclusive tour of Origin's labs located...

This is the 17th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring the history of eugenics and the ways it shapes our present. The series is organized by Osagie K. Obasogie in...

THE INSTAGRAM POST, precision-guided by sex and age, had zeroed in on its target. Yuchen Tu is a conser­vatory-trained viola...

This is the 16th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Rebecca Brice, ABC News | 07.05.2012

Australian researchers have discovered that the rate of perinatal deaths in IVF (in vitro fertilisation) can be considerably reduced when...

By Rebecca Brice, ABC News | 07.05.2012

Australian researchers have discovered that the rate of perinatal deaths in IVF (in vitro fertilisation) can be considerably reduced when...

By Meghan Neal, New York Daily News | 07.04.2012

A California woman is suing the federal government, arguing she should have the right to be artificially inseminated by a...

By Meghan Neal, New York Daily News | 07.04.2012

A California woman is suing the federal government, arguing she should have the right to be artificially inseminated by a...

By Alice Park, Time / CNN | 07.03.2012
How much would it take for you to consider selling your bone marrow? A U.S. appeals court puts the price...
By Alice Park, Time / CNN | 07.03.2012
How much would it take for you to consider selling your bone marrow? A U.S. appeals court puts the price...
By Adam Feuerstein, The Street | 07.03.2012

Osiris Therapeutics "disappeared" important data when the company announced results Monday from a mid-stage study of its stem cell therapy...

By Adam Feuerstein, The Street | 07.03.2012

Osiris Therapeutics "disappeared" important data when the company announced results Monday from a mid-stage study of its stem cell therapy...